Watch the highlights of CSF Course Director, Joel Schlessinger, MD‘s Q & A session with the “Skin Cancer Epidemic: Mohs Update” panelists on some of the controversies related to skin cancer treatments: the expansion of XRT and the increasing number of biopsies by non-dermatologists.
Skin Cancer Epidemic: Mohs Updatecontroversies in Skin Cancer Treatmentsincreasing number of biopsies by non-dematologistsuse of XRT in private practiceAAD physician statementbiopsy ten or more lesionsprioritizing biopsy sites and treatCosmeticsENTOculoplasticCME Accreditationmedicaltraditional dermatologypracticalhonestinsightfuldiscussion basedbiopsiescosmetic surgeryCosmetic Surgery ForumdermatologyfeatureJoel SchlessingerM. Laurin Councilmohsmohs surgeryMurad AlamPlastic SurgeryQ&ARhett Druggeskin cancerskin cancer treatmentsXRT
The Importance of Inclusion and Diversity in Aesthetic Medicine
- March 4, 2020
Lashes, Lasers and Lifts: The Past, Present and Future of Lash Enhancement
- February 20, 2020
CBD and Cosmetics: Does CBD really work?
- January 14, 2020
What Does Your Website Say About Your Practice?
- November 12, 2019
Does Creativity in Aesthetic Medicine Matter?
- October 8, 2019